PhysiologyNature Cardiovascular ResearchPeer-reviewed
✦ In-depth digest
Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy
Stephanie Anderson, Anja Karlstaedt, Megan Young…·Dunja Aksentijević
In db/db mice, six weeks of AZD1656 improved diastolic function, cardiac metabolism and infarct size, with increased Treg infiltration and less fibrosis, without glycaemic change.
4 citationstop 1%